Additionally, in the Syrian hamster model of COVID-19, the drug reduced the lung titers of the Alpha, Beta, and Delta variants, apparently possessing the highest activity against the latter, while the lung titer decrease observed for the Omicron variant did not reach statistical significance [ 50 ]. 3.2.
← all excerpts
Molnupiravir Revisited-Critical Assessment of Studies in Animal Models of COVID-19.
1
—
—